Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Other Accumulated Expenses (2021 - 2023)

Werewolf Therapeutics (HOWL) has disclosed Other Accumulated Expenses for 3 consecutive years, with $1.6 million as the latest value for Q2 2023.

  • Quarterly Other Accumulated Expenses fell 86.41% to $1.6 million in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Jun 2023, down 86.41% year-over-year, with the annual reading at $6.5 million for FY2022, N/A changed from the prior year.
  • Other Accumulated Expenses for Q2 2023 was $1.6 million at Werewolf Therapeutics, down from $4.1 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $11.8 million in Q2 2022, with the low at $20000.0 in Q1 2021.
  • Average Other Accumulated Expenses over 3 years is $5.8 million, with a median of $5.3 million recorded in 2022.
  • Peak annual rise in Other Accumulated Expenses hit 86.41% in 2023, while the deepest fall reached 86.41% in 2023.
  • Over 3 years, Other Accumulated Expenses stood at $20000.0 in 2021, then soared by 32560.0% to $6.5 million in 2022, then crashed by 75.41% to $1.6 million in 2023.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $1.6 million, $4.1 million, and $6.5 million for Q2 2023, Q1 2023, and Q4 2022 respectively.